Simon TL, et al. Rossi’s principles of transfusion medicine. Wiley Online Library; 2016.
Kaufman RM, et al. Platelet transfusion: a clinical practice guideline from the AABB. Ann Intern Med. 2015;162(3):205–13.
Gupta S, Paliczak A, Delgado D. Evidence-based indications of platelet-rich plasma therapy. Expert Rev Hematol. 2021;14(1):97–108.
Article CAS PubMed Google Scholar
Everts P, et al. Platelet-rich plasma: new performance understandings and therapeutic considerations in 2020. Int J Mol Sci. 2020;21(20):7794.
Article CAS PubMed PubMed Central Google Scholar
Dos Santos RG, et al. The regenerative mechanisms of platelet-rich plasma: a review. Cytokine. 2021;144: 155560.
Schallmoser K, et al. Production and quality requirements of human platelet lysate: a position statement from the working party on cellular therapies of the international society of blood transfusion. Trends Biotechnol. 2020;38(1):13–23.
Article CAS PubMed Google Scholar
Nebie O, et al. Can the administration of platelet lysates to the brain help treat neurological disorders? Cell Mol Life Sci. 2022;79(7):379.
Article CAS PubMed PubMed Central Google Scholar
Johnson J, et al. Prospective therapeutic applications of platelet extracellular vesicles. Trends Biotechnol. 2021;39(6):598–612.
Article CAS PubMed Google Scholar
Shih DT, Burnouf T. Preparation, quality criteria, and properties of human blood platelet lysate supplements for ex vivo stem cell expansion. N Biotechnol. 2015;32(1):199–211.
Article CAS PubMed Google Scholar
Burnouf T, et al. Human platelet lysate: replacing fetal bovine serum as a gold standard for human cell propagation? Biomaterials. 2016;76:371–87.
Article CAS PubMed Google Scholar
Bieback K, et al. Gaps in the knowledge of human platelet lysate as a cell culture supplement for cell therapy: a joint publication from the AABB and the International Society for Cell & Gene Therapy. Transfusion. 2019;59(11):3448–60.
Henschler R, et al. Human platelet lysate current standards and future developments. Transfusion. 2019;59(4):1407–13.
De Pascale MR, et al. Platelet derivatives in regenerative medicine: an update. Transfus Med Rev. 2015;29(1):52–61.
Burnouf T, et al. Blood-derived biomaterials and platelet growth factors in regenerative medicine. Blood Rev. 2013;27(2):77–89.
Article CAS PubMed Google Scholar
Gomes FG, et al. Synergy of human platelet-derived extracellular vesicles with secretome proteins promotes regenerative functions. Biomedicines. 2022;10(2):238.
Article CAS PubMed PubMed Central Google Scholar
Lu Y, et al. Platelet for drug delivery. Curr Opin Biotechnol. 2019;58:81–91.
Article CAS PubMed Google Scholar
He M, et al. The role of allogeneic platelet-rich plasma in patients with diabetic foot ulcer: current perspectives and future challenges. Front Bioeng Biotechnol. 2022;10: 993436.
Article PubMed PubMed Central Google Scholar
Liao X, et al. Allogeneic platelet-rich plasma therapy as an effective and safe adjuvant method for chronic wounds. J Surg Res. 2020;246:284–91.
Article CAS PubMed Google Scholar
Zhu X, et al. Efficacy of intra-articular injection of allogeneic platelet-rich plasma for knee osteoarthritis combined with hematologic blood dyscrasias with platelet dysfunction: protocol of a randomized, double-blind, placebo-controlled trial. BMC Musculoskelet Disord. 2022;23(1):1095.
Article CAS PubMed PubMed Central Google Scholar
Velier M, et al. Production of platelet-rich plasma gel from elderly patients under antithrombotic drugs: perspectives in chronic wounds care. Platelets. 2018;29(5):496–503.
Article CAS PubMed Google Scholar
Niemann M, et al. Individual immune cell and cytokine profiles determine platelet-rich plasma composition. Arthritis Res Ther. 2023;25(1):6.
Article CAS PubMed PubMed Central Google Scholar
Harrison P, et al. The use of platelets in regenerative medicine and proposal for a new classification system: guidance from the SSC of the ISTH. J Thromb Haemost. 2018;16(9):1895–900.
Article CAS PubMed Google Scholar
Alsousou J, et al. The role of platelet-rich plasma in tissue regeneration. Platelets. 2013;24(3):173–82.
Article CAS PubMed Google Scholar
Anitua E, Prado R, Orive G. Allogeneic platelet-rich plasma: at the dawn of an off-the-shelf therapy? Trends Biotechnol. 2017;35(2):91–3.
Article CAS PubMed Google Scholar
Mastrogiacomo M, et al. Innovative cell and platelet rich plasma therapies for diabetic foot ulcer treatment: the allogeneic approach. Front Bioeng Biotechnol. 2022;10: 869408.
Article PubMed PubMed Central Google Scholar
Romano V, et al. Allogeneic solid platelet-rich plasma for persistent epithelial neurotrophic defects: a protocol and pilot study. Cornea. 2023;42(4):498–506.
Akbarzadeh S, et al. Allogeneic platelet-rich plasma: is it safe and effective for wound repair? Eur Surg Res. 2021;62(1):1–9.
Article CAS PubMed Google Scholar
El-Gohary R, et al. Using intra-articular allogenic lyophilized growth factors in primary knee osteoarthritis: a randomized pilot study. Regen Med. 2021;16(2):113–5.
Article CAS PubMed Google Scholar
Marchand M, et al. Serum drops for ocular surface disease: national survey of Canadian cornea specialists. Can J Ophthalmol. 2018;53(3):266–71.
Drew VJ, et al. Reflections on dry eye syndrome treatment: therapeutic role of blood products. Front Med (Lausanne). 2018;5:33.
Gabriel C, et al. Eye drops of human origin-Current status and future needs: report on the workshop organized by the ISBT Working Party for Cellular Therapies. Vox Sang. 2023;118(4):301–9.
Council of Europe—20th Edition of the Guide to the preparation, use and quality assurance of blood components. https://www.edqm.eu/en/blood-guide, C.o. Europe, Editor. 2022: Strasbourg, France.
World Health Organization Guidelines on good manufacturing practices for blood establishments, Annex 4, TRS No 961. https://www.who.int/publications/m/item/gmp-for-blood-establishments-annex-4-trs-no-961. 2011.
Burnouf T. Modern plasma fractionation. Transfus Med Rev. 2007;21(2):101–17.
Article PubMed PubMed Central Google Scholar
Michelson AD, et al. Platelets. Academic press; 2019.
Sender R, Fuchs S, Milo R. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. 2016;14(8): e1002533.
Article PubMed PubMed Central Google Scholar
Estcourt L, et al. Guidelines for the use of platelet transfusions. Br J Haematol. 2016;176(3):365.
WHO Model Lists of Essential Medicines 2021 https://www.who.int/groups/expert-committee-on-selection-and-use-of-essential-medicines/essential-medicines-lists. 2021.
Al-Riyami AZ, et al. Quality of evidence-based guidelines for platelet transfusion and use: a systematic review. Transfusion. 2021;61(3):948–58.
Schenone M, Furie BC, Furie B. The blood coagulation cascade. Curr Opin Hematol. 2004;11(4):272–7.
Article CAS PubMed Google Scholar
Rapaport SI, Rao LVM. The tissue factor pathway: how it has become a “prima ballerina.” Thromb Haemost. 1995;74(07):007–17.
Norris LA. Blood coagulation. Best Pract Res Clin Obstet Gynaecol. 2003;17(3):369–83.
Davie EW. Biochemical and molecular aspects of the coagulation cascade. Thromb Haemost. 1995;74(07):001–6.
Comments (0)